Zante Greg

Avg. Two Year Performance

No purchase track record
50% Avg. Sale Return
22% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return16%15%13%3%50%
Sale Success Rate7 of 74 of 76 of 76 of 75 of 7
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 187.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

VP, Finance & Administration:

Holdings: 0.69K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--